Search
Search Results
-
Improved survival of Burkitt lymphoma/leukemia patients: observations from Poland, 1999–2020
The aim of this study was to estimate the survival of Polish Burkitt lymphoma/leukemia (BL) patients diagnosed between 1999 and 2017, considering...
-
Successful pseudo-autologous stem cell transplantation for donor-derived Burkitt lymphoma occurring 9 years after allogeneic transplantation
Donor-derived hematological malignancies have been recognized as rare but serious late complications in allogeneic hematopoietic stem cell...
-
Spontaneous tumor lysis syndrome (STLS) during biopsy for burkitt lymphoma: a case report
BackgroundTumor lysis syndrome (TLS) is a hematologic oncological emergency characterized by metabolic and electrolyte imbalances. On breakdown of...
-
-
Diagnostic approaches and future directions in Burkitt lymphoma and high-grade B-cell lymphoma
Since the 2016 WHO update, progress has been made in understanding the biology of Burkitt lymphoma (BL) and the concept of high-grade B-cell...
-
MYC directly transactivates CR2/CD21, the receptor of the Epstein–Barr virus, enhancing the viral infection of Burkitt lymphoma cells
MYC is an oncogenic transcription factor dysregulated in about half of total human tumors. While transcriptomic studies reveal more than 1000 genes...
-
Long-term outcomes in patients with Burkitt lymphoma older than 65 years: an analysis of the Texas Cancer Registry
Burkitt lymphoma (BL) is an extremely aggressive but curable subtype of non-Hodgkin lymphoma. While younger patients have excellent outcomes in...
-
Optimal dosage of rituximab for children with Burkitt lymphoma
The current chemotherapy treatments have led to an improvement in survival rates for pediatric Burkitt’s lymphoma (BL). Survival in children with...
-
Burkitt-type lymphoma incidentally found as the cause of acute appendicitis: a case report and review of literature
BackgroundAppendectomy remains one of the most common emergency operations. Recent research supports the treatment of uncomplicated appendicitis with...
-
Sustained high-efficiency daily diafiltration using a mediator-adsorbing membrane in Burkitt lymphoma with a very high risk of tumor lysis syndrome: a case series with literature review
BackgroundTumor lysis syndrome is an oncological emergency triggered by the rapid release of intracellular materials from lysed malignant cells....
-
Non-Hodgkin lymphoma mimicking acute leukemia: a report of six cases and review of the literature
Aggressive subtypes of non-Hodgkin lymphoma may uncommonly be referred to clinical oncologists for treatment of acute leukemia, due to an elevated or...
-
Current Approaches of Immune Checkpoint Therapy in Chronic Lymphocytic Leukemia
Increasing understanding of the complex interaction between leukemic and immune cells, which is responsible for tumor progression and immune evasion,...
-
The evolution of acute lymphoblastic leukemia research and therapy at MD Anderson over four decades
Progress in the research and therapy of adult acute lymphoblastic leukemia (ALL) is accelerating. This analysis summarizes the data derived from the...
-
Tumor lysis syndrome followed by tumor regression after COVID-19 in a patient with chronic lymphocytic leukemia
Coronavirus disease 2019 (COVID-19) can become lethal in patients with hematological malignancies; however, several cases of tumor regression after...
-
Novel Biological Insights and New Developments in Management of Burkitt Lymphoma and High-Grade B-Cell Lymphoma
Burkitt lymphoma (BL) is highly curable, and prompt institution of therapy is critical to achieving optimal outcomes. Although current “standard”...
-
Preclinical characterization and clinical trial of CFI-400945, a polo-like kinase 4 inhibitor, in patients with relapsed/refractory acute myeloid leukemia and higher-risk myelodysplastic neoplasms
CFI-400945 is a selective oral polo-like kinase 4 (PLK4) inhibitor that regulates centriole duplication. PLK4 is aberrantly expressed in patients...
-
Acute left ventricular insufficiency in a Burkitt Lymphoma patient with myocardial involvement and extensive local tumor cell lysis: a case report
BackgroundBurkitt lymphoma (BL) is a rare disease with the sporadic variant accounting for less than 1% of adult non-Hodgkin lymphomas. BL usually...
-
Serum interleukin-33 and soluble suppression of tumorigenicity 2 in pediatric leukemia with febrile neutropenia
The purpose of this study was to evaluate the association between interleukin-33 (IL-33) and its receptor Soluble Suppression of Tumorigenicity-2...
-
Burkitt and Burkitt-Like Lymphomas: a Systematic Review
Purpose of ReviewBurkitt’s lymphoma and its leukemic form (Burkitt cell acute lymphoblastic leukemia) are a highly aggressive disease. We review the...
-
Rituximab administration in pediatric patients with newly diagnosed acute lymphoblastic leukemia
Polyethylene glycol (PEG)-asparaginase (pegaspargase) is a key agent in chemotherapy for acute lymphoblastic leukemia (ALL), but recipients...
